Nephrocare Health Services Ltd
NSE:NEPHROPLUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nephrocare Health Services Ltd
NSE:NEPHROPLUS
|
IN |
Wall St Price Targets
NEPHROPLUS Price Targets Summary
Nephrocare Health Services Ltd
According to Wall Street analysts, the average 1-year price target for NEPHROPLUS is 795.6 INR with a low forecast of 666.6 INR and a high forecast of 1 050 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NEPHROPLUS's stock price target?
Price Target
795.6
INR
According to Wall Street analysts, the average 1-year price target for NEPHROPLUS is 795.6 INR with a low forecast of 666.6 INR and a high forecast of 1 050 INR.
What is the Revenue forecast for Nephrocare Health Services Ltd?
Projected CAGR
15%
Over the last 2 years, the compound annual growth rate for Revenue has been 33%. The projected CAGR for the next 7 years is 15%.
What is the Operating Income forecast for Nephrocare Health Services Ltd?
Projected CAGR
16%
Over the last 2 years, the compound annual growth rate for Operating Income has been 67%. The projected CAGR for the next 7 years is 16%.
What is the Pre-Tax Income forecast for Nephrocare Health Services Ltd?
Projected CAGR
75%
Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 71%. The projected CAGR for the next 2 years is 75%.
What is the Net Income forecast for Nephrocare Health Services Ltd?
Projected CAGR
48%
Over the last 2 years, the compound annual growth rate for Net Income has been 48%. The projected CAGR for the next 3 years is 48%.
